title: The U.K. Prospective Diabetes Study. A review.
abstract: The objective of the U.K. Prospective Diabetes Study (UKPDS), initiated in 1977, was set up to determine whether improved blood glucose control in people with type 2 diabetes will prevent the complications of diabetes. The UKPDS was also designed to determine whether there are differences between conventional policy (diet therapy) and three different regimens of intensive treatment policy, based on sulfonylurea, metformin, or insulin. Interim efficacy analyses revealed that the intensive policies with sulfonylurea, insulin, and metformin were equally effective in reducing fasting plasma glucose concentrations. However, glucose and HbA1c measurements steadily increased with time, reflecting ongoing deterioration of beta-cell function. Cardiovascular disease was the major cause of complications, and the risk factors included raised LDL cholesterol concentrations, low HDL cholesterol concentrations, elevated blood pressure, elevated HbA1c concentrations, and smoking. A final study report was issued in September 1998, when the median duration of therapy was 11 years.
authors.affiliation: University of Oxford, Nuffield Department of Clinical Medicine, Radcliffe Infirmary, U.K.
authors.forename: R C
authors.initials: RC
authors.lastname: Turner
mesh_terms: D000328:Adult; D000368:Aged; D001786:Blood Glucose / Q000378:metabolism*; D003710:Demography; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000150:complications* / Q000628:therapy; D003925:Diabetic Angiopathies / Q000209:etiology / Q000517:prevention & control; D003927:Diet, Diabetic; D005500:Follow-Up Studies; D006801:Humans; D006973:Hypertension / Q000209:etiology / Q000517:prevention & control; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000378:metabolism; D008875:Middle Aged; D011446:Prospective Studies; D006113:United Kingdom
chemical_list: D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin